Treatment of Hepatic Encephalopathy With Flumazenil and Change in Cortical GABA Levels in MRS
Clinical trial NCT02048969 · WITHDRAWN
Trial details
- NCT number
- NCT02048969
- Sponsor
- Yale University
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-01
- Primary completion
- 2017-10-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.